COMBANTRIN 125 mg, tablet 6 tablets
Active ingredients: Pyrantel pamoate, Pyrantel
Commercialized according to BDPM
Tablet6 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- COMBANTRIN 125 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 6 comprimé(s)
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Dec 1973
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69990800CIP73140629CIP133400931406297Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EMBONATE DE PYRANTELcomprimé | 360,2 mg · un comprimé | SA |
| PYRANTEL BASEcomprimé | 125,0 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.